Drug Makers Relieved As Europe's Unitary Patent Gets Predictable Boost

The Advocate General of the Court of Justice of the European Union has dismissed Spain’s second challenge to the unitary patent, offering more legal certainty for drug manufacturers and pointing the way towards reduced litigation costs.